Long term administration of agonists could potentially lead to unanticipated consequences in these organs
McClung MR, Lewiecki EM, Cohen SB, Bolognese MA, Woodson GC, Moffett AH, et al (2006) Denosumab in postmenopausal women with low bone mineral density: Commentary
Real World Impact: Current Use and Outcomes These medications are no longer niche, they're influencing population level trends: Rapid Growth in Use In the U.S., reported use of GLP-1 weight loss drugs has more than doubled in the past year, from about 5.8% of adults in early 2024 to over 12% in 2025 Women tend to use these medications at higher rates than men, with 15.2% vs
Make sure your everyday grab-and-go choices reflect your goals
If you're taking tirzepatide for sleep apnea, drinking alcohol could directly counteract your treatment efforts by making your OSA worse